The European Health Summit, hosted by the European Business Summits, is an annual gathering where businesses, policymakers, and academics come together to discuss important healthcare issues in Europe and beyond.

PAST Speakers

Didier Reynders

European Commissioner for Justice

Martin Kocher

Minister for Labour and Economy, Austria

Emer Cooke

Executive Director of the European Medicines Agency

Laurent Muschel

Acting Director-General of HERA 

Giorgos Rossides

Head of Cabinet of Commissioner Kyriakides

Pernille Weiss

Member of the European Parliament

Colin Scicluna

Head of Cabinet of Vice President Šuica

Dolors Montserrat

Member of the European Parliament

Lars Fruergaard Jørgensen

CEO, Novo Nordisk

Tomislav Sokol

Member of the European Parliament

Sara Cerdas

Member of the European Parliament

Carlos Montañés

Executive Vice-President, HIPRA

Haseeb Ahmad

President, Europe at Novartis

Jeffrey Francer

Vice President, Global Regulatory Affairs Policy, Eli Lilly

Massimo Giorgio Visentin

Eastern Europe Cluster President, Pfizer

Nathalie Moll

Director General, EFPIA

Dr. Gaudenz Silberschmidt

Director, Health and Multilateral Partnerships at the WHO

Adam Hacker

Director and Global Head Regulatory Affairs at CEPI

Francesca Colombo

Head of the Health Division, OECD

Irene Norstedt

Director People Directorate, DG Research and Innovation European Commission

Maya Matthews

Deputy Director for Digital, EU4Health and Health Systems Modernisation at DG SANTE

Prof. Karl Broich

President, Federal Institute for Drugs and Medical Devices

Josep Figueras

Director and Cofounder of the European Observatory on Health Systems and Policies

Dipak Kalra

President, The European Institute for Innovation through Health Data

Anca Toma

Executive Director of the European Patients’ Forum

Simone Boselli

Public Affairs Director, Eurordis

Charlotte Marchandise

Executive Director at the European Public Health Association (EUPHA)

Andrea Corazza

Senior Director, Policy & Government Affairs Europe, Novavax

Enrique Terol

Health Counsellor, Spanish Permanent Representation to the EU

Menno Kok

Managing Director, EIT Health

Elizabeth Kuiper

Associate Director, European Policy Centre

José Peres

Senior Coordinator of the National Associations Council at EuropaBio

Prof. Claire Paquet

Neurologist, Assistance Publique – Hôpitaux de Paris

Tamsin Rose

EU Health Reporter

Mariam Zaidi

International News Presenter

Sarah-Taïssir Bencharif

EU Health Journalist

Giedrė Peseckytė

EU Health Reporter, Euractiv

Andy Bounds

Financial Times Correspondent

Arnaud Thysen

Director General, European Business Summits

Felicia Balan

Health Project Manager, European Business Summits

EHS Weekly updates

EU Commissioner Didier Reynders will deliver a keynote speech at the 2023 edition of the European Health Summit on patients’ health data protection, taking into account the new European Health Data Space file. 

The biotechnological pharmaceutical company HIPRA is joining EHS 2023, bringing its expertise as an established entity focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service:

For a 100% European pharmaceutical company like HIPRA, being part of the European Business Summit is a thrilling opportunity to contribute to the policy debate that will help build a resilient European Health Union.

Already a central topic at the European Health Summit (Summer Edition) and the focus of the October task force meeting, the Summit will address the EU Pharma Legislation, emphasising the need to strengthen the competitiveness and innovation of the healthcare system, with the ultimate aim of reaching autonomy.

The rapporteur of the directive of the EU Pharma Legislation, Member of the European Parliament Pernille Weiss will join EHS 2023 to discuss the next steps ahead for creating a competitive and innovative European healthcare system.

A longtime partner of EBS and participant to several task forces, Eli Lilly will be present at the 2023 edition of the European Health Summit to advance the discussion regarding an EU pharmaceutical strategy aimed at enhancing Europe’s global competitiveness.

EHS 2023 will explore the EU Commission’s €156 million initiative on NCDs in Europe, investigating how to ensure that such expenditure will have a positive impact for patients and what approaches are needed to reduce avoidable premature death while moving towards a preventative approach. Although the EU has unveiled a Beating Cancer Plan, how can the EU show more ambition towards diabetes and cardiovascular disease?

The rapporteur of the European Health Data Space, Member of the European Parliament Tomislav Sokol will join the 2023 edition of the European Health Summit, providing his insights on EU digital health, the secondary use of data and more. 

The European Federation of Pharmaceutical Industries and Associations will participate to EHS 2023 to bring forward the debate on a pharma strategy to foster Europe’s competitiveness on a global scale.

A growing and aging global population strains healthcare systems. To enhance resilience, EHS 2023 will address factors like nutrition, sustainable food, environment, agriculture, fisheries, and climate policies in healthcare. The urgency of a One Health approach, spanning all sectors, is evident due to the COVID-19 pandemic and other disease outbreaks with their societal and economic consequences.

Make your voice heard
& join the debate!

Be heard

Choose the format that suits your strategy to reach key stakeholders: either thematic summits or tailor-made live bebates and interviews

Be seen

EBS has a database comprised of 17,000 contacts from the policy sector (40%), private sector (40%) and academia/Think Tanks (20%)

Learn from thought leaders

High-level EU representatives, C-level speakers and experts share their insights and bring complementary perspectives on key economical, political and social challenges.

Co-shape the debate

Co-shape your session together with EBS: from defining a session subject to selecting a panel composition and stakeholder outreach.